Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NCAB's new mammography recommendations will affect federal health programs coverage.

This article was originally published in The Gray Sheet

Executive Summary

MAMMOGRAPHY COVERAGE BY FEDERAL HEALTH PROGRAMS WILL CHANGE in accordance with new National Cancer Advisory Board recommendations for women in their forties, President Clinton and HHS Secretary Donna Shalala announced March 27 at the White House. The announcement followed the National Cancer Institute NCAB's same-day release of recommendations supporting routine screening mammography for women ages 40-49 and several weeks of public debate on the appropriateness of such screening.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT007830

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel